Abstract
This study investigates the role of NLRP3 inflammasome and its main effector Caspase-1 in inflammation and alveolar bone resorption associated with periodontitis. Heat-killed Aggregatibacter actinomycetemcomitans (Aa) was injected 3x/week (4 weeks) into gingival tissues of wild-type (WT), Nlrp3-KO and Caspase1-KO mice. Bone resorption was measured by µCT and osteoclast number was determined by tartrate-resistant acid phosphatase (TRAP) staining. Inflammation was assessed histologically (H/E staining and immunofluorescence of CD45 and Ly6G). In vitro studies determined the influence of Nlrp3 and Caspase-1 in Rankl-induced osteoclast differentiation and activity and on LPS-induced expression of inflammation-associated genes. Bone resorption was significantly reduced in Casp1-KO but not in Nlrp3-KO mice. Casp1-KO mice had increased in osteoclast numbers, whereas the inflammatory infiltrate or on gene expression were similar to those of WT and Nlrp3-KO mice. Strikingly, osteoclasts differentiated from Nlrp3-deficient macrophages had increased resorbing activity in vitro. LPS-induced expression of Il-10, Il-12 and Tnf-α was significantly reduced in Nlrp3- and Casp1-deficient macrophages. As an inceptive study, these results suggest that Nlrp3 inflammasome does not play a significant role in inflammation and bone resorption in vivo and that Caspase-1 has a pro-resorptive role in experimental periodontal disease.
Similar content being viewed by others
Introduction
Inflammasomes are cytosolic multiprotein complexes activated in response to various stimuli, including both microbial-associated molecular patterns (MAMPs) and damage-associated molecular patterns (DAMPs). A major biological function is the final processing of various inflammation-associated cytokines, including IL-1β, IL-18 and IL-33, into the biologically active form1. The relevance of inflammasomes to the immune response is demonstrated by the association between mutations in the genes encoding their protein components and autoimmune inflammatory conditions, or dysregulation of the immune response2,3. NLRP3 is the most studied inflammasome and has been associated with various diseases and conditions characterized by chronic inflammation, including gout, cancer, type 2 diabetes and rheumatoid arthritis, besides periodontal diseases1,4,5,6.
Periodontal disease is a chronic inflammatory condition induced by microbial insult derived from a highly complex dental biofilm and is the most prevalent lytic lesion of bone in humans7,8. This condition represents and excellent model to study the role of inflammasomes due to the abundance of MAMPs and DAMPs and the elevated proportion of macrophages in the tissue microenvironment.
Interestingly, there is a relative scarcity of information on the biological roles of inflammasomes derived from clinical or pre-clinical studies in periodontal disease models. Increased expression of IL-1β and IL-18 in the gingival tissues and gingival crevicular fluid of patients with various forms of periodontal disease9,10,11 correlates positively with increased expression of NLRP3 mRNA in this microenvironment12, suggesting the participation of this inflammasome in the pathogenesis of periodontal disease. The possible involvement of NLRP3 inflammasome is further suggested by the increased expression of NLRP3 in the oral epithelium13 and in the saliva of periodontal disease patients14.
The canonical effector protein activated downstream of most inflammasomes is the protease Caspase-1, which cleaves the pro-form of inflammatory cytokines IL-1β, IL-18 and IL-33, generating their mature secreted forms. Caspase-1 can also induce cell death by pyroptosis15. Osteoblasts express inflammasome components, including the core protein of NLRP3 inflamasome, NALP316. Activation of Caspase-1 leads to cell death by pyroptosis of osteoprogenitor cells17. Infection of osteoblastic cells with Aa induced production of IL-1β and IL-18 and apoptosis, both events mediated by the activation of NLRP3 inflammasome18. These events may affect bone turnover and inflammatory bone resorption in vivo. Cytokines processed by the effector caspase-1, particularly IL-1β, may modulate osteoclast differentiation and activity by direct effects on osteoclasts19 or by indirectly modulating the expression of RANKL (ligand for receptor activator of nuclear factor-kappa-B) by other cell types20.
There is only one study assessing the role of NLRP3 inflammasome in a Pg-colonization model of experimental periodontitis that reported a reduction in pro-inflammatory cytokine production and resorption of alveolar bone21; however we did not find any studies assessing the relevance of Caspase-1 in this disease model. This inceptive study intends to contribute to bridge this gap of knowledge, by providing insights into the role NLRP3 inflammasome and of Caspase-1 on inflammation and alveolar bone resorption in a murine model of bacterial-induced experimental periodontal disease.
Materials and Methods
Periodontal disease model
A total of 36 C57BL/6 male adult mice (age between 6 and 8 weeks) were used, including 12 wild-type (WT) mice, 12 mice genetically deficient (knockout) for Nalp3 (Nrlp3-KO), the central NLR protein in the NLRP3 inflammasome, and 12 mice genetically deficient for Caspase-1 (Casp1-KO). All mice were obtained from the Center for genetically modified and transgenic mice, School of Medicine at Ribeirao Preto-University of Sao Paulo (USP). Disruption of the targeted genes was verified at mRNA and protein level (Supplemental Fig. 1). This study was carried out in accordance with the principles stated by the Brazilian College of Animal Experimentation and was approved by the Ethical Committee on Animal Experimentation (protocol number 06/2014) of the School of Dentistry at Araraquara, UNESP-State University of Sao Paulo, Araraquara, SP, Brazil.
Experimental periodontal disease was induced in 18 mice, including 6 animals of each genotype (WT, Nlrp3-KO and Casp1-KO) by direct bilateral injections of a 3 uL PBS suspension of heat-killed Aggregatibacter actinomycetemcomitans (Aa, JP1 serotype) at 1×109 UFC/mL22,23. 18 non-disease control mice (n = 6 for each genotype) received bilateral injections of the same volume of the PBS vehicle. These injections were performed under mild general anesthesia with isofluorane (Baxter Healthcare, Deerfield, IL) using a Hamilton-type microsyringe (33 gauge needle) three times/week for 4 weeks, directly in the gingival tissues at the palatal aspect between the first and second upper molars. All animals were euthanized by cervical dislocation 4 weeks after the first injection.
The maxillary bones were hemisected and submitted to microcomputed tomographic analysis of alveolar bone resorption. After scanning, the specimens were submitted to routine EDTA decalcification and processing to obtain paraffin-embeded tissue blocks for the histological and immunofluorescence analyses.
In vitro studies
Primary M-csf-differentiated macrophages were derived from cells obtained from the marrow of long bones (femur and tibia) of WT, Nlrp3-KO and Casp1-KO mice as previously described24. These cells were plated in regular tissue culture-treated and calcium phosphate-coated (Osteologic, Corning-Costar, Corning, NY, USA) 96-well plates (1×104 cells/well) and after 18 h, stimulated with 50 ng/mL of murine recombinant Rankl and 20 ng/mL of murine recombinant M-csf (Peprotech Inc, Rocky Hill, NJ, USA). Medium was changed and these stimuli re-applied at 72 h. Cultures were kept for an additional 48 h (a total of 5 days of osteoclastic differentiation). Cells grown in regular tissue culture-treated plastic were fixed with paraformaldehyde and permeabilized in saponin-containing buffer (BD Cytofix/Cytoperm, BD Biosciences, San Jose, CA, USA) and stained with AlexaFluor 488-conjugated phalloidin (Molecular Probes, ThermoFisher Scientific, Waltham, MA, USA) for 40 minutes, followed by DNA staining with DAPI (Sigma-Aldrich Co., St. Louis, MO, USA) for 5 minutes for the identification of actin ring formation. Total RNA was also isolated in parallel experiments for RT-qPCR. Both M-csf differentiated macrophages (20 ng/mL for 2 days) and Rankl/M-csf differentiated osteoclasts grown in regular 96-well tissue culture plates (1×105 macrophages/well, 1×104 bone marrow cells/well for osteoclasts) were lysed for RNA isolation. Macrophages were stimulated with 100 ng/mL of LPS (E.coli LPS, Sigma-Aldrich Co., St Louis, MO, USA) or with the same volume of PBS vehicle for 18 h. Cells grown on calcium phosphate-coated 96-well plates were lysed by incubation in 1% sodium hypochloride for 15 min. Three digital images from each well (covering > 80% of the well surface) of phalloidin/DAPI-stained and of calcium-phosphate coated plates were obtained at 40X magnification on an inverted digital fluorescence microscope (Evos fl, AMG Micro, ThermoFisher Scientific, Waltham, MA, USA). A trained examiner blind to the experimental conditions counted the number of osteoclasts (cells with evidence of actin ring formation and containing three or more nuclei) and measured the perimeter of the osteoclasts in the merged green/blue channel fluorescent images. In the images from calcium phosphate-coated wells, the area of exposed plastic was measured as indicative of resorbing activity. A trained examiner not aware of the experimental conditions performed these measurements using ImageJ software (v. 1.51 s, National Institutes of Health, USA – http://imagej.nih.gov/ij).
Microcomputed tomography analysis (µCT scanning)
The hemimaxillae were initially fixed in 4% buffered formalin for 24 h and transferred to 70% alcohol until scanning using 56 kV, 300 mA and a 0.5 mm aluminum attenuation filter, with the resolution of the slices set to 18 µm using a µCT system (Skyscan, Aartselaar, Belgium). Tridimensional images were reconstructed and the resulting images were oriented in three planes (sagittal, coronal and frontal) in a standardized manner using anatomical landmarks with NRecon and DataViewer softwares (Skyscan, Aartselaar, Belgium). A standardized 5.4 mm3 region of interest (ROI) was set with 1.5×4.0×0.9 mm (vertical or cervico-apical x horizontal or mesio-distal x lateral or buccal-palatal). This cuboidal ROI was positioned on the central sagittal section (identified by the diameter of the root canal in the distal root of the first molar) using the following references: 1. cervical/coronal reference was the roof of the furcation area between mesial and distal roots of the upper first molar; 2. mesially we used the distal aspect of the mesial root of the first molar. The thickness of the ROI was set to 50 slices (900 µm) counted from this central section towards the palatal/medial direction on the sagittal plane. For the analysis, a standardized threshold of grey level was set to distinguish between non-mineralized and mineralized tissues. Considering that variations on the size and mineralization of the tooth structures included in the ROI were irrelevant among the different animals, the analysis assessed the percentage of mineralized tissue (MT) within the total volume (TV) of the ROI, presented as a ratio (MT/TV). A decrease on this ratio is interpreted as indicative of bone resorption.
Histological analysis
The hemimaxillae with intact surrounding soft tissues were fixed in 4% buffered formalin for 48 h, decalcified in EDTA (0.5 M, pH 8.0) for 45 days at room temperature, and embedded in paraffin. Semi-serial sections of 4 µm thickness were obtained in the buccal-lingual (frontal plane) direction and stained with hematoxylin and eosin (H/E).
Immunohistochemical staining of TRAP
Nine unstained semi-serial sections from each paraffin-embedded hemimaxillae spanning 1000 µm on the antero-posterior direction (sagittal plane, n = 6 animals/experimental condition and genotype) were used for detection of tartrate resistant acid phosphatase (TRAP) expression. Briefly, the sections were deparafinized in xylene and rehydrated in decreasing concentrations of ethanol. Endogenous peroxidase was blocked using 3% peroxide in methanol (5 min, RT), followed by antigen retrieval by heating (95–98 C) the sections in tris/EDTA buffer (pH 9.0) for 15 min and blocking (1 h, RT) of non-specific binding with 2% BSA. Primary antibody for TRAP (cat# ab191406, Abcam, Cambridge, MA, USA) was diluted (1:100) in background-reducing solution (Dako-Agilent, Santa Clara, CA, USA) and incubated overnight at 4 C. The detection reaction was developed using a HRP-DAB visualization system (LSAB2, Dako-Agilent, Santa Clara, CA, USA). Osteoclasts were identified as large TRAP-positive cells, containing three or more nuclei located in the vicinity of the alveolar bone. A single trained examiner who was blind to the coding identifying the experimental groups and genotypes counted the osteoclasts (at 40X magnification) located from the apical portion of the palatal root of the first molar along the periodontal ligament upwards to the alveolar bone crest and towards the center of the palate, adjacent to the depression on the palatal bone associated with the major palatine artery and nerve.
Immunofluorescence analysis of the inflammatory infiltrate
Unstained semi-serial sections of 4 µm thickness (9 sections per animal and experimental group, spanning 900 µm in the sagittal plane) were deparaffinized in two changes of xylenes for 15 and 5 minutes, and then dehydrated in 100% ethanol for 2 minutes. The slides were then rehydrated through a graded ethanol series (95% and 70%) for 2 minutes each, followed by a wash in distilled water for 1 minute, and then placed in Trilogy buffer (Cell Marque, Hot Springs, AR, USA) at 96.5 C for 25 minutes. Slides were cooled in a distilled water bath for 5 minutes, and rinsed in 1x TBS (Tris-Buffered Saline). Sections were permeabilized with 0.1% Triton X-100 (ThermoFisher Scientific, Waltham, MA, USA) and blocked in 1X PBS-T (0.5% Tween 20) containing 10% normal goat serum (Life Technologies, ThermoFisher Scientific, Waltham, MA, USA) at room temperature for 30 minutes. Slides were washed with 1x TBS and incubated with primary antibodies diluted in 1x TBS for 24 h at 4 C. Primary antibodies and dilutions used were as follows: CD45 at 1:200 (rat IgG, purified anti-mouse CD45, Biolegend, San Diego, CA, USA), for ‘general’ leukocyte infiltration, and Ly6G at 1:100 (rat IgG, purified anti-mouse Ly6G, Biolegend, San Diego, CA, USA), for specific neutrophil (PMN) staining. Negative control included irrelevant rat IgG at 1:100 dilution. Tissues were washed three times for 5 minutes each in 1x TBS and incubated with goat anti-rat secondary antibody conjugated with AlexaFluor 594 (ThermoFisher Scientific, Waltham, MA, USA) at 1:650 and 1:200, respectively, for 2 hours, at room temperature. The DNA dye 4’,6-diamidino-2-phenylindole (DAPI) was used to counterstain cell nuclei. Images were obtained on an EVOS fl digital inverted microscope (ThermoFisher Scientific, Waltham, MA, USA), and the median fluorescence intensity (MFI) in the red channel was determined using Image J software (v. 1.51 s, National Institutes of Health, USA – http://imagej.nih.gov/ij).
Quantitative Reverse-Transcription Real-Time PCR
Total RNA was extracted from bone marrow-differentiated macrophages and Rankl/M-csf-differentiated osteoclasts (n = 7 samples from independent experiments, assessed in triplicate) using affinity columns (RNAqueous-4PCR, Ambion Inc, Invitrogen Corp., Foster City, CA, US) according to the manufacturer’s protocol. The quantity and purity of total RNA were determined by UV spectrophotometry and by the 260/280 nm ratio, respectively. 500 ng of total RNA was converted into cDNA using random hexamer primers and moloney leukemia virus reverse transcriptase in a reaction volume of 20 uL (High Capacity cDNA Synthesis kit, Applied Biosystems, Invitrogen Corp., Foster City, CA, USA). The qPCR reactions were performed in a 20 µL total volume reaction, including TaqMan qPCR mastermix (TaqMan Fast Advanced, Applied Biosystems, Invitrogen Corp., Foster City, CA, USA), cDNA template, deionized water, and mouse-specific pre-designed and optimized sets of primers and probe (TaqMan gene expression assays, Applied Biosystems, Invitrogen Corp., Foster City, CA, USA; supplemental table 1). Cycling conditions were pre-optimized by the supplier of the sets of primers/probe and master mix, and 40 cycles were run on a StepOne Plus qPCR thermocycler (Applied Biosystems, Invitrogen Corp., Foster City, CA, USA). Relative levels of gene expression were determined by the ∆(∆Ct) method using the thermocycler’s software and automated detection of the Ct. Expression of 18 S RNA in the same samples was used to normalize the results of the target genes.
Statistical analysis
The statistical analysis was performed using Prism 8.3 (GraphPad Software LLC, San Diego, CA, USA). Central tendency and dispersion measures were calculated from different experiments. Comparisons between the experimental conditions (control/vehicle versus disease/stimulated) within each genotype background (WT, Nlrp3-KO, Casp1-KO) were performed using unpaired t-tests with Welch’s correction. Comparisons among the different genotypes (WT, Nlrp3-KO, Casp1-KO) in each experimental condition (control/vehicle versus disease/stimulated) were performed using Brown-Forsythe and Welch’s ANOVA followed by post-hoc test for pairwise comparisons. Significance level was set at 95% (p < 0.05) for all analyses.
Results
Inflammatory bone resorption is attenuated in Casp1-KO, but not in NLRP3-KO mice
Interestingly, µCT analysis showed a greater volume of mineralized tissue (MT) in non-disease control (PBS-injected) Nlrp3-KO and Casp1-KO animals in comparison with WT mice. Injection of heat-killed Aa effectively induced alveolar bone resorption in all genotypes, but the severity of resorption was significantly attenuated in Casp1-KO mice (Fig. 1A,B). These results suggest that Nlrp3 and Caspase-1 may have a role in physiological bone turnover and that Caspase-1, but not Nlrp3, has a role in promoting inflammatory bone resorption.
(A) Representative images of tridimensional reconstructions of microcomputed tomography scans of the hemimaxillae from WT, Nlrp3-KO and Casp1-KO mice, according to the experimental condition (non-disease control/PBS-injected or diseased/Aa-injected). Scale bar of 1 mm. (B) Alveolar bone resorption was evaluated as the change in the ratio between mineralized tissue (MT) to the total volume (TV) of the standardized region of interest (ROI). Images from 6 different animals (12 hemimaxillae, n = 6) from each genotype and experimental condition were analyzed. Bars represent means and vertical lines standard deviations. The asterisk (*) indicates a significant difference between control (PBS-injected) and diseased (Aa-injected) specimens in each genotype (WT, Nlrp3-KO and Casp1-KO) (unpaired t-test with Welch’s correction). Different letters indicate statistically significant differences among control (PBS-injected, a-c) or diseased (Aa-injected, d-e) specimens across all three genotypes (Brown-Forsythe and Welch’s ANOVA followed by Dunnett’s multiple comparisons test).
Osteoclast number is increased in Casp-1 KO mice
Considering the attenuation of bone resorption in Casp1-KO mice, the increase in the number of osteoclasts associated with the induction of experimental periodontal disease was surprisingly similar in all genotypes. Osteoclasts are identified as large, positively-stained multinucleated cells located in the vicinity of alveolar bone (indicated by arrows in Fig. 2A). These results indicate that osteoclast differentiation in this inflammatory microenvironment is not affected by the lack of Nlrp3 or Caspase-1. In fact, counter-intuitively lack of Caspase-1 significantly increased osteoclast numbers, but not bone resorption (Fig. 2B). There is a slight increase in osteoclast numbers in Nlrp3-KO mice, but it was not statistically significant.
(A) Representative images of immunohistochemistry for TRAP in the periodontal tissues, both in non-disease control (PBS-injected) and diseased (Aa-injected) mice, according to the different genotypes (WT, Nlrp3-KO and Casp1-KO). Large, multinucleated positively cells near the alveolar bone were counted as osteoclasts (40×, arrows indicate osteoclasts, BC the bone crest, and R the palatal root of the first molar). (B) Bars indicate means and vertical lines the standard deviation of the number of osteoclasts according to the experimental condition (non-disease control / PBS-injected and diseased/Aa-injected) and genotype (WT, Nlrp3-KO and Casp1-KO). The quantification was performed in 9 different and non-sequential sections spanning 1000 µm on the sagittal plane (antero-posterior) from 6 different animals in each experimental condition (non-disease control/PBS-injected and diseased/Aa-injected) and genotype (WT, Nlrp3-KO and Casp1-KO). The asterisk (*) indicates a significant difference between control (PBS-injected) and diseased (Aa-injected) specimens in each genotype (WT, Nlrp3-KO and Casp1-KO) (unpaired t-test with Welch’s correction). Different letters indicate statistically significant differences among control (PBS-injected, a-b) or diseased (Aa-injected, d-e) specimens across all three genotypes (Brown-Forsythe and Welch’s ANOVA followed by Dunnett’s multiple comparisons test).
Infiltration of PMNs is attenuated in Casp1-KO mice
Induction of experimental periodontal disease was associated with a marked increase in inflammatory cell infiltrate in WT, Nlrp3-KO mice and Casp1-KO mice (Fig. 3A, inflamed area corresponding to the site of injections indicated by an asterisk, ‘BC’ indicates the alveolar bone crest and ‘R’ indicates the palatal root of the upper first molar, H/E stained images). Immunofluorescence analysis (Fig. 3B) shows a marked increase on leukocyte (CD45 + ) infiltration in the gingival tissues of WT, Nlrp3-KO and Casp1-KO mice. There was no statistically significant difference on the overall inflammatory infiltrate (CD45 + cells) in diseased gingival tissues among the three genotypes; however there was a significant decrease on the PMN (Ly6G + ) infiltrate in Casp1-KO mice, which also had the least relative increase of PMN infiltration with the induction of experimental periodontal disease.
(A) Representative images of H/E-stained sections of each experimental group (non-disease control/PBS-injected or diseased/Aa-injected) according to the genotype (WT, Nlrp3-KO or Casp1-KO) at 100X magnification (BC, bone crest, R, palatal root of the first molar, * indicates inflammation in the injection area) (B) Representative images of immunofluorescence detection of the pan-leukocyte marker CD45 and the neutrophil marker Ly6G in the gingival tissues of WT, Nlrp3 and Casp1-KO mice, according to the experimental condition (non-disease control/PBS-injected or diseased/Aa-injected). Nuclei were counterstained with DAPI. The results for the quantitation of mean fluorescence intensity (MFI) in the red channel (AlexaFluor 594) of CD45 or Ly6G according to the experimental condition and genotype are presented in the graphs. Nine semi-serial sections from each animal and experimental condition spanning 900 µm in the sagittal (antero-posterior) plane. Bars represent means and vertical lines the standard deviation of MFI values from at least 4 animals per group and experimental condition (Brown-Forsythe and Welch’s ANOVA followed by Dunnett’s multiple comparisons test).
LPS-induced expression of Il-10, Il-12 and Tnf-α is reduced in Nlrp3- and Casp1-deficient macrophages
Considering that bacterial LPS is a major disease-inducing antigen in periodontal diseases, we assessed the role of Nlrp3 and Caspase-1 on the expression of the inflammation- and macrophage phenotype-associated genes Il-10, Il-12 and Tnf-α in primary bone marrow-derived macrophages. In WT and Nlrp3-deficient macrophages, LPS stimulation caused a statistically significant increase in Il-10, Il-12 and Tnf-α, whereas in Casp1-deficient macrophages only Il-10 was significantly induced. In comparison with WT macrophages, expression of all three candidate genes was markedly reduced in Nlrp3- and Casp1-deficient macrophages, although the inhibition of Il-12 expression was not statistically significant (Fig. 4).
Expression (mRNA) of selected candidate genes associated with macrophage phenotype and inflammation. Bone marrow-derived macrophages from WT, Nlrp3- and Casp1-KO mice were differentiated with M-csf (20 ng/mL) over 48 h and then stimulated with LPS (100 ng/mL) for 4 h. Unstimulated cells were treated with the same volume of PBS vehicle. Expression of Il-10, Il-12 and Tnf-α was determined by RT-qPCR using Taqman chemistry and pre-designed sets of primers and probe. Bars represent means and vertical lines the standard deviation of normalized target gene expression (n = 7 independent experiments, assessed in triplicate). The asterisk (*) indicates a significant difference in comparison with unstimulated cells (Unpaired t-test with Welch’s correction). Double asterisks (**) in the bracketed columns indicate significant difference (Brown-Forsythe and Welch’s ANOVA followed by Dunnett’s multiple comparisons test).
Caspase-1 and Nlrp3-deficiency increases the activity of Rankl-derived osteoclasts in vitro
Macrophages from the bone marrow of WT, Casp1-KO and Nlrp3-KO mice differentiated into osteoclasts when treated with Rankl and M-csf over 5 days. The osteoclasts derived from Nlrp3-KO mice were significantly larger, which justifies the reduction in number of osteoclasts due to the limited cell growth area (Fig. 5A). Moreover, osteoclasts differentiated from the bone marrow cells of both Nlrp3- and Casp1-KO mice had a significantly greater resorbing activity than the osteoclasts derived from the bone marrow of WT mice (Fig. 5B, the clear areas indicated by asterisks in the images result from resorption of the calcium phosphate coating by the osteoclasts). Mmp-9 expression was also increased upon osteoclast differentiation by treatment with RANKL over 5 days. Osteoclasts derived from the bone marrow of Nlrp3-KO mice had significantly greater expression of Mmp-9 in comparison with osteoclasts derived from the bone marrow of WT animals (Fig. 5B).
(A) Representative images of actin ring formation in osteoclasts differentiated from bone marrow-derived macrophages isolated from WT, Nlrp3-KO and Casp1-KO mice (40×, scale bar 1000 µm). Bars represent means and vertical lines the standard deviation of osteoclast numbers and of the perimeter normalized to the number of osteoclasts assessed. Asterisk (*) indicates a significant difference between bracketed bars (Brown-Forsythe and Welch’s ANOVA followed by Dunnett’s multiple comparisons test). (B) Representative images of pit assay using Calcium phosphate-coated plates indicating the resorptive activity (clear area of exposed plastic substrate indicated by asterisks results from the removal of Calcium phosphate coating by the osteoclasts) of osteoclasts according to the genotype of the mice (40×, scale bar 1000 µm). Quantification of resorptive activity and Mmp-9 mRNA expression are depicted in the graphs. Bars represent means and vertical lines the standard deviation (n = 7 independent experiments, analyzed in triplicate) of the area of exposed plastic substrate (top) and normalized Mmp-9 mRNA expression (bottom). The asterisk (*) indicates a significant difference between resorbed area in WT osteoclasts in comparison to osteoclasts derived from Nlrp3- and Casp1-KO mice (Brown-Forsythe and Welch’s ANOVA followed by Dunnett’s multiple comparisons test).
Discussion
To our knowledge, this is the first study to assess the role of Caspase-1 in an in vivo model of bacterial-induced periodontal disease. The results indicate that the Nlrp3 inflammasome does not have a relevant role in the inflammatory bone resorption in this model. These results should be considered in the context of an inceptive study, generating insights and questions that shall be further explored in future studies. Inactivation of Caspase-1 gene significantly attenuated inflammatory bone resorption; however this effect was not accompanied by a reduction in the number of osteoclasts, on the inflammatory infiltrate or on the transcription of selected candidate genes associated with inflammation and mineralized and non-mineralized soft tissue degradation. These results are in contrast with those of a study that used a Porphyromonas gingivalis oral colonization model of experimental periodontitis, which showed a significant attenuation of bone resorption in Nlrp3-deficient mice21. The differences in experimental design (oral colonization with live bacteria versus direct injection of heat killed bacteria), in the bacterial species used (P.gingivalis versus A.actinomycetemcomitans) and in the methods of assessment of bone resorption (histomorphometric linear measurements X µCT tridimensional volumetric analysis) may account for the discrepancy. Importantly, the limitations of the experimental approach in the present study have to be considered when interpreting the data, particularly the lack of data on protein production (most notably of IL-1β, the prototypical NLRP3 inflammasome-activated cytokine) and of data exploring the biological mechanisms involved in the observed phenotype.
Interestingly, most in vivo and in vitro studies related with periodontal disease used the Gram-negative bacterial species Porphyromonas gingivalis (Pg) as the exogenous stimulus. In spite of its relevance to periodontitis, Pg is not the only bacterial species associated with periodontal diseases in the subgingival dental biofilm; and some studies have demonstrated that other microbial species, such as Streptococcus sanguis25, Mycoplasma salivarium26, Fusobacterium nucleatum (Fn)27 and Aggregatibacter actinomycetemcomitans (Aa)28 also regulate the expression of NLRP3 inflammasome components and of the inflammasome-processed cytokines. In fact, there is evidence that NLRP3 is differentially regulated by secreted products from supra and subgingival biofilms29, as well as conflicting information regarding the inhibitory30,31,32,33 or stimulatory33,34,35,36,37,38 effect of Pg and Pg-derived antigens on NLRP3 expression and activation. These conflicting reports are related with the assessment of different cell types, Pg-derived antigen used, experimental design (e.g., second signal for inflammasome activation, experimental period, outcomes assessed) and on the presence or absence of hypoxia.
In this study we used heat-killed Gram-negative bacteria associated with periodontal disease in humans to avoid issues with possible fluctuation of bacterial cell viability and also issues with adherence/colonization in the oral environment. In vitro studies show that Aggregatibacter actinomycetemcomitans (Aa, used in this study) induces expression of NLRP3 and IL-1β by human monocytes39 and human PBMCs40. Some studies report that leukotoxin secreted by Aa is a crucial virulence factor mediating the induction of IL-1β and IL-1841; however, another in vitro study using human monocytes infected with mutant strains of Aa (knockout for leukotoxin and cytolethal dystending toxin genes) also showed increased expression of IL-1β, IL-18 and NLRP3, suggesting that other molecules derived from Aa may activate inflammasomes40. This supports the possibility of inflammasome activation in our model using heat-killed Aa, which is further indicated by our in vitro data (Supplemental Fig. 2) demonstrating the agonistic effect of heat-killed Aa on bone marrow-derived macrophages.
The goal of our model was to induce an inflammatory response and the associated inflammatory alveolar bone resorption, the two major hallmarks of periodontal disease. This model provides the two signals that are required for activation of the Nlrp3 inflammasome: exogenous microbial-derived PAMPs, which triggers the production of cytokine precursors (e.g., pro-IL1); and a second signal, represented by the interaction of DAMPs with their PRRs (e.g., RAGE, HMGB1). The two-signal model of activation of NLRP3 was already demonstrated in the context of periodontal disease by stimulating primary gingival epithelial cells with Porphyromonas gingivalis, which resulted in downregulation of NLRP3 expression and increase of pro-interleukin-1β expression. Increased secretion of interleukin-1β was only detected upon stimulation with extracellular ATP as the danger signal/second signal34.
In addition to the presence of specific ligands/activators of NLRP3, the chronic inflammatory microenvironment of periodontal disease is characterized by high levels of reactive oxygen species (ROS), hypoxia33 and also by tissue degradation, with accumulating DAMPs. Both ROS and DAMPs (which may also induce production of ROS) can activate multiple inflammasomes besides NLRP3, including AIM2, NLRP1, NLRC4 and NLRP642. Thus, inflammasome activation may derive from direct recognition/interaction of bacterial and host-derived ligands by the inflammasome central/sensor proteins coupled with the detection of cell changes induced by external microbial/stress stimuli43. Specifically regarding periodontal disease, there is scarce information available. Increased gene expression of NLRP3 and NLRP2, but not of ASC-1, was reported in the presence of periodontal disease in humans, and these increased levels of inflammasome core genes were correlated with increased mRNA of IL-1β and IL-18, cytokines processed by the inflammasomes12. Increased expression of NLRP3 and AIM2 in the gingival tissues of patients with periodontal disease is positively correlated with the levels of IL-1β and IL-18, suggesting that various inflammasomes may participate in the microbial-induced inflammation in periodontal diseases35. In our experimental model, it is important to consider that only the NLRP3 inflammasome was disrupted in Nlrp3-KO mice (Supplemental Fig. 1) and this may cause a compensatory activation of the other functional inflammasomes (e.g., NLRC4, AIM2), with a shift in the biological effects. In fact, induction of experimental arthritis in Il10-KO mice caused a significant increase in the expression of Nalp3, Aim2 and Caspase-144. Nevertheless, the lack of functional Nlrp3 did not affect the inflammatory infiltrate and alveolar bone resorption in this model. In contrast, genetically modified mice with a global gain of function mutation of Nlrp345 demonstrated increased production of proinflammatory mediators, which was associated with altered bone turnover and reduced bone mass; however when the Nlrp3 gain of function mutation was limited to osteoclasts there was no increase in proinflammatory cytokines accompanying the decrease of bone mass46. Rankl-induced osteoclast differentiation in vitro was not affected in Caspase-1 and Nlrp3-deficient macrophages, but cell size, resorbing activity and Mmp-9 expression of the resulting osteoclasts were all significantly increased in comparison with bone marrow-derived macrophages from WT mice.
LPS induction of Il-10, Il-12 and Tnf-α was significantly reduced in Nlrp3- and Casp1-deficient macrophages, suggesting that Nlrp3 influences Tlr4-associated gene expression. This is surprising, considering that a major biological function of inflammasomes is the posttranslational processing of cytokines and that LPS stimulation is usually considered as a first signal priming macrophages for inflammasome activation. In our experiments, the 18h-stimulation period may have allowed for the production of molecules that provide an autocrine/paracrine second stimulatory signal for the activation of inflammasomes. Prolonged stimulation of macrophages with LPS has been recently shown to promote the maturation and secretion of IL-1β independently of Nlrp3 activation47. However, both constitutive and LPS-induced expression of Il-10 is reported to be significantly reduced in Nlrp3-deficient murine macrophages, even with a shorter period of stimulation (4 h)48. The mechanism associated with this possible crosstalk between TLR signaling and the NLRP3 inflammasome is unknown, but at least for IL-10 it is independent of the major signaling pathways activated downstream of TLR4 (p38 and ERK MAPKinases and NF-kB)48. It is also possible that lack of LPS-induced posttranslational modifications of Nlrp349,50,51 in the macrophages derived from Nlrp3-KO mice is involved in inhibition of cytokine expression. Moreover, we cannot rule out the involvement of non-canonical Caspase-11 inflammasome in regulating the responses of macrophages to LPS in the cytosol52,53, although it is still unclear how LPS may enter the cells. Interestingly, the Caspase-11 non-canonical inflammasome can also induce a non-canonical activation of the Nlrp3 inflammasome54.
Various possible scenarios may be implicated in these intriguing and apparently contradictory findings in vitro. In vivo, osteoclast-precursor cells may be derived from a different population of precursor cells influenced by a much more complex microenvironment that includes other inflammatory and stromal cell types, as well as multiple biologically-active molecules, including cytokines, chemokines, lipid-derived mediators, as opposed to the more simple and defined microenvironment of the in vitro experiments. Also, the experimental periods in vitro are not commensurable with the experimental periods of the in vivo experiment. These possibilities will be further investigated in subsequent studies.
Since Caspase-1 is the main downstream effector of all inflammasomes, Casp1-KO mice may be considered as representative of a global inflammasome loss of function, which in our experimental model was associated with a significant attenuation of inflammatory bone resorption, indicating that Caspase-1 activation in the microenvironment of periodontal disease has a relevant role in the inflammatory bone resorption. We speculate that activation of other Caspase-1 activating inflammasomes may compensate the inactivation of Nlrp3 in Nlrp3-KO mice, which may account for the lack of influence on bone resorption associated with experimental periodontitis in these mice. Strikingly, inflammatory infiltrate, osteoclastogenesis and expression of candidate inflammatory genes were not affected by the lack of Caspase-1 in our experimental model, which contrasts with the phenotype of attenuated bone resorption. Speculatively, lack of Caspase-1 may cause a functional impairment and/or a phenotypical change through both direct and indirect influences on the cascade of events in inflammatory cells and osteoclasts; such as a shift towards the activation of the non-canonical Caspase-11 inflammasome by bacteria phagocytosed by macrophages in our experimental model. The significant impairment in PMN infiltration observed in Casp1-KO mice suggests that PMNs may play a role in alveolar bone resorption in this model and supports a phenotypical change in the inflammatory response. Interestingly, our in vitro data indicates that RANKL-induced osteoclastic differentiation is not affected in Casp1-deficient macrophages, which supports the in vivo finding of a similar number of TRAP-positive osteoclasts in WT and Casp1-KO mice. However, in vitro RANKL-differentiated osteoclasts derived from bone marrow macrophages from Nlrp3- and Casp1-deficient macrophages were larger and presented significantly increased resorptive activity, which would be expected to increase bone resorption in vivo. It is possible that this discrepancy is due to the presence of other biologically active mediators (besides Rankl and M-csf used in vitro) and cell types in the microenvironment in vivo, which may have reduced the resorbing activity. We speculate that osteoclast differentiation and activation are distinct processes that may be regulated independently. These possibilities will be explored in future experiments. In addition, these results indicate that other inflammatory pathways are involved in the pathogenesis of periodontal diseases, as inflammation and alveolar bone resorption were not completely abrogated in either Nlrp3- or Casp1-KO mice.
The suggestion is that inflammasome activation may affect bone turnover indirectly (i.e., via modulation of the level of active proinflammatory mediators) or directly (i.e., via an osteoclast-specific effect). The osteoclast-specific effect may not be necessarily associated with change in osteoclast number (i.e., osteoclast differentiation), but rather with increased osteoclast activity, as indicated by the in vitro experiments (Fig. 5A,B). On the other hand, selective blockage of Nlrp3 in vitro has been shown to reduce RANKL-induced osteoclastogenesis in vitro44. These contrasting results may be associated with differences in the experimental approach, particularly the use of bone marrow-derived macrophages from Il10-KO mice and the criterium used to identify the osteoclasts among the TRAP-positive cells, as cell size and the presence of three or more nuclei were not considered. Of note, we did not assess the infiltration of macrophages, important osteoclast precursors and prototypical inflammasome-expressing cells, in the gingival tissues. It is possible that changes in macrophage infiltrate and/or phenotype play a role in the observed phenotype of Nlrp3- and Casp1-KO mice. The influence of Nlrp3 inflammasome and Caspase-1 activities on in vitro chemotaxis and infiltration of macrophages in vivo, as well as on the phenotype of macrophages need to be explored in subsequent studies.
In summary, NLRP3 inflammasome did not play a significant role in inflammation and bone resorption in the heat-killed Aa-induced periodontal disease model; whereas lack of Caspase-1 attenuated inflammatory bone resorption and the infiltration of PMNs. Taken in the context of an inceptive study, the apparent contradictions and insights from the data presented are stimulating of further research into biological mechanisms by which inflammasomes can influence destruction of both soft and mineralized connective tissues in chronic inflammatory conditions associated with host-microbial interactions.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Shibata, K. Historical aspects of studies on roles of the inflammasome in the pathogenesis of periodontal diseases. Molecular oral microbiology 33, 203–211 (2018).
Jin, Y. et al. NALP1 in vitiligo-associated multiple autoimmune disease. The New England journal of medicine 356, 1216–1225 (2007).
Valk, K. et al. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers. Oncology 79, 283–292 (2010).
Schroder, K. & Tschopp, J. The inflammasomes. Cell 140, 821–832 (2010).
Mathews, R. J. et al. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals of the rheumatic diseases 73, 1202–1210 (2014).
Larsen, C. M. et al. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes care 32, 1663–1668 (2009).
Teng, Y. T. et al. Periodontal immune responses of human lymphocytes in Actinobacillus actinomycetemcomitans-inoculated NOD/SCID mice engrafted with peripheral blood leukocytes of periodontitis patients. Journal of periodontal research 34, 54–61 (1999).
Pacios, S. et al. Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 26, 1423–1430 (2012).
Orozco, A., Gemmell, E., Bickel, M. & Seymour, G. J. Interleukin-1beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral microbiology and immunology 21, 256–260 (2006).
Johnson, R. B. & Serio, F. G. Interleukin-18 concentrations and the pathogenesis of periodontal disease. Journal of periodontology 76, 785–790 (2005).
Engebretson, S. P., Grbic, J. T., Singer, R. & Lamster, I. B. GCF IL-1beta profiles in periodontal disease. Journal of clinical periodontology 29, 48–53 (2002).
Bostanci, N. et al. Expression and regulation of the NALP3 inflammasome complex in periodontal diseases. Clinical and experimental immunology 157, 415–422 (2009).
Xue, F., Shu, R. & Xie, Y. The expression of NLRP3, NLRP1 and AIM2 in the gingival tissue of periodontitis patients: RT-PCR study and immunohistochemistry. Archives of oral biology 60, 948–958 (2015).
Isaza-Guzman, D. M., Medina-Piedrahita, V. M., Gutierrez-Henao, C. & Tobon-Arroyave, S. I. Salivary Levels of NLRP3 Inflammasome-Related Proteins as Potential Biomarkers of Periodontal Clinical Status. Journal of periodontology 88, 1329–1338 (2017).
Fernandes-Alnemri, T., Yu, J. W., Datta, P., Wu, J. & Alnemri, E. S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509–513 (2009).
McCall, S. H. et al. Osteoblasts express NLRP3, a nucleotide-binding domain and leucine-rich repeat region containing receptor implicated in bacterially induced cell death. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 23, 30–40 (2008).
Almeida, M. Q. et al. Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: a link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors. Human molecular genetics 20, 165–175 (2011).
Zhao, P., Liu, J., Pan, C. & Pan, Y. NLRP3 inflammasome is required for apoptosis of Aggregatibacter actinomycetemcomitans-infected human osteoblastic MG63 cells. Acta histochemica 116, 1119–1124 (2014).
Jimi, E. et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Experimental cell research 247, 84–93 (1999).
Hofbauer, L. C. et al. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25, 255–259 (1999).
Yamaguchi, Y., Kurita-Ochiai, T., Kobayashi, R., Suzuki, T. & Ando, T. Regulation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated periodontal disease. Inflammation research: official journal of the European Histamine Research Society… [et al.] 66, 59–65 (2017).
Chaves de Souza, J. A. et al. NOD1 in the modulation of host-microbe interactions and inflammatory bone resorption in the periodontal disease model. Immunology 149, 374–385 (2016).
Souza, J. A. et al. Role of NOD2 and RIP2 in host-microbe interactions with Gram-negative bacteria: insights from the periodontal disease model. Innate immunity 22, 598–611 (2016).
Liu, X. & Quan, N. Immune Cell Isolation from Mouse Femur Bone Marrow. Bio-protocol 5 (2015).
Saeki, A. et al. Activation of nucleotide-binding domain-like receptor containing protein 3 inflammasome in dendritic cells and macrophages by Streptococcus sanguinis. Cellular microbiology 19 (2017).
Sugiyama, M. et al. Activation of inflammasomes in dendritic cells and macrophages by Mycoplasma salivarium. Molecular oral microbiology 31, 259–269 (2016).
Bui, F. Q. et al. Fusobacterium nucleatum infection of gingival epithelial cells leads to NLRP3 inflammasome-dependent secretion of IL-1beta and the danger signals ASC and HMGB1. Cellular microbiology 18, 970–981 (2016).
Shenker, B. J. et al. Aggregatibacter actinomycetemcomitans cytolethal distending toxin activates the NLRP3 inflammasome in human macrophages, leading to the release of proinflammatory cytokines. Infection and immunity 83, 1487–1496 (2015).
Bostanci, N., Meier, A., Guggenheim, B. & Belibasakis, G. N. Regulation of NLRP3 and AIM2 inflammasome gene expression levels in gingival fibroblasts by oral biofilms. Cellular immunology 270, 88–93 (2011).
Belibasakis, G. N., Guggenheim, B. & Bostanci, N. Down-regulation of NLRP3 inflammasome in gingival fibroblasts by subgingival biofilms: involvement of Porphyromonas gingivalis. Innate immunity 19, 3–9 (2013).
Taxman, D. J. et al. Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis. The Journal of biological chemistry 287, 32791–32799 (2012).
Huck, O., Elkaim, R., Davideau, J. L. & Tenenbaum, H. Porphyromonas gingivalis-impaired innate immune response via NLRP3 proteolysis in endothelial cells. Innate immunity 21, 65–72 (2015).
Cheng, R. et al. Porphyromonas gingivalis-Derived Lipopolysaccharide Combines Hypoxia to Induce Caspase-1 Activation in Periodontitis. Frontiers in cellular and infection microbiology 7, 474 (2017).
Yilmaz, O. et al. ATP-dependent activation of an inflammasome in primary gingival epithelial cells infected by Porphyromonas gingivalis. Cellular microbiology 12, 188–198 (2010).
Park, E. et al. Activation of NLRP3 and AIM2 inflammasomes by Porphyromonas gingivalis infection. Infection and immunity 82, 112–123 (2014).
Fleetwood, A. J. et al. Metabolic Remodeling, Inflammasome Activation, and Pyroptosis in Macrophages Stimulated by Porphyromonas gingivalis and Its Outer Membrane Vesicles. Frontiers in cellular and infection microbiology 7, 351 (2017).
Yamaguchi, Y., Kurita-Ochiai, T., Kobayashi, R., Suzuki, T. & Ando, T. Activation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated atherosclerosis. Pathogens and disease 73 (2015).
Yoshida, K. et al. PKR induces the expression of NLRP3 by regulating the NF-kappaB pathway in Porphyromonas gingivalis-infected osteoblasts. Experimental cell research 354, 57–64 (2017).
Kelk, P. et al. Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin. Cell death & disease 2, e126 (2011).
Belibasakis, G. N. & Johansson, A. Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine 59, 124–130 (2012).
Kelk, P., Claesson, R., Chen, C., Sjostedt, A. & Johansson, A. IL-1beta secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin. International journal of medical microbiology: IJMM 298, 529–541 (2008).
Yilmaz, O. & Lee, K. L. The inflammasome and danger molecule signaling: at the crossroads of inflammation and pathogen persistence in the oral cavity. Periodontology 2000 69, 83–95 (2015).
Greaney, A. J., Leppla, S. H. & Moayeri, M. Bacterial Exotoxins and the Inflammasome. Frontiers in immunology 6, 570 (2015).
Greenhill, C. J. et al. Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction. Arthritis research & therapy 16, 419 (2014).
Bonar, S. L. et al. Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PloS one 7, e35979 (2012).
Qu, C. et al. NLRP3 mediates osteolysis through inflammation-dependent and -independent mechanisms. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 29, 1269–1279 (2015).
Hong, S. & Yu, J. W. Prolonged Exposure to Lipopolysaccharide Induces NLRP3-Independent Maturation and Secretion of Interleukin (IL)-1beta in Macrophages. Journal of microbiology and biotechnology 28, 115–121 (2018).
Kobayashi, M. et al. NLRP3 Deficiency Reduces Macrophage Interleukin-10 Production and Enhances the Susceptibility to Doxorubicin-induced Cardiotoxicity. Scientific reports 6, 26489 (2016).
Ghonime, M. G. et al. Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function. Journal of immunology 192, 3881–3888 (2014).
Juliana, C. et al. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. The. Journal of biological chemistry 287, 36617–36622 (2012).
Py, B. F., Kim, M. S., Vakifahmetoglu-Norberg, H. & Yuan, J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Molecular cell 49, 331–338 (2013).
Kayagaki, N. et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341, 1246–1249 (2013).
Yi, Y. S. Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses. Immunology 152, 207–217 (2017).
Pellegrini, C., Antonioli, L., Lopez-Castejon, G., Blandizzi, C. & Fornai, M. Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation. Frontiers in immunology 8, 36 (2017).
Acknowledgements
FAPESP grants to CRJ and FRGR (2014/04926–8 and 2014/17544–6), CAPES AUXPE 655/2014. The authors also wish to thank Leandro Alves dos Santos (academic support staff, UNESP-State University of Sao Paulo, School of Medicine, Botucatu-SP, Brazil) and Ana Claudia Gregolin Costa Miranda (Academic Support Staff, UNESP-State University of Sao Paulo, School of Dentistry, Araraquara-SP, Brazil) for their support in the histological processing.
Author information
Authors and Affiliations
Contributions
F.R.G., A.E.D., J.A.C.S. and L.A.G.-M. performed the experiments tabulated and analyzed the data, S.M.W. interpreted the data and revised the manuscript, C.R.J. conceived the study, interpreted the data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rocha, F.R.G., Delitto, A.E., de Souza, J.A.C. et al. Relevance of Caspase-1 and Nlrp3 Inflammasome on Inflammatory Bone Resorption in A Murine Model of Periodontitis. Sci Rep 10, 7823 (2020). https://doi.org/10.1038/s41598-020-64685-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-020-64685-y